secwatch.observer — SEC 8-K summary
======================================

Issuer:     AVENUE THERAPEUTICS, INC. (ATXI)
CIK:        0001644963
Form:       8-K
Filed at:   2025-11-18T23:59:59+00:00
Accession:  0001437749-25-035624
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.08, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Avenue Therapeutics sets Dec 30, 2025 annual meeting; Nov 28 deadline for proposals
--------------------------------------------------------------------------------

- Annual meeting scheduled for December 30, 2025; proxy statement to be filed with SEC.
- Shareholder proposals for proxy inclusion under Rule 14a-8 must be received by November 28, 2025.
- Director nominations and other non-14a-8 proposals also due by November 28, 2025.
- All proposals must be submitted in writing to Corporate Secretary at Bay Harbor Islands address.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1644963/000143774925035624/0001437749-25-035624-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1644963/000143774925035624/atxi20251118c_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-035624

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer